Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 1999, p. 2305-2306, Vol. 43, No. 9
Unité des Rickettsies, CNRS UPRES-A
6020, Faculté de Médecine, Université de la
Méditerranée, Marseille, France
Received 26 April 1999/Returned for modification 27 May
1999/Accepted 24 June 1999
Thalidomide was evaluated for its in vitro activity against
Encephalitozoon species by using the MRC-5 cell system. A
cytotoxic effect was observed for concentrations of 101
µg/ml (P < 105) and 5 µg/ml
(P < 105). Thalidomide did not
significantly inhibit the growth of any of the microsporidia under
study. These data suggest that thalidomide is not an etiologic
treatment in microsporidial enteritis.
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Lack of In Vitro Antimicrosporidian Activity
of Thalidomide
*
Corresponding author. Mailing address: Unité des
Rickettsies, Faculté de Médecine, 27 Boulevard Jean Moulin,
13385 Marseille cedex 5, France. Phone: 33 (0) 4.91.32.43.75. Fax. 33 (0) 4.91.83.03.90. E-mail:
Michel.Drancourt{at}medecine.univ-mrs.fr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»